Feature Channels: Blood

Filters close
Newswise:Video Embedded surgeons-address-the-urgent-need-to-eliminate-blood-deserts
VIDEO
Released: 7-Nov-2024 10:00 AM EST
Surgeons Address the Urgent Need to Eliminate ‘Blood Deserts’
American College of Surgeons (ACS)

Surgeons at the forefront of trauma and critical care surgery discussed at a recent news conference the urgent need to make quick access to blood more widely available to injured patients before they arrive at a hospital.

Newswise: Health Research Launches Into Orbit to Discover How Spaceflight Affects Blood
Released: 4-Nov-2024 4:30 PM EST
Health Research Launches Into Orbit to Discover How Spaceflight Affects Blood
University of Utah Health

NASA crew and ground-based scientists are sending blood cells to the International Space Station on November 4 to learn why astronauts have a higher risk of blood clots.

Newswise: Ivan Maillard Named Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center
4-Nov-2024 10:00 AM EST
Ivan Maillard Named Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center

Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

Newswise: Standing Desk Not the Answer to Decreasing Blood Pressure, Research Shows
Released: 30-Oct-2024 10:45 AM EDT
Standing Desk Not the Answer to Decreasing Blood Pressure, Research Shows
West Virginia University

Alternating between sitting and standing at work decreases sedentary behavior, but it has no effect on lowering blood pressure, according to a study led by a West Virginia University epidemiologist. Researchers also found that too much standing during work may have negative effects on cardiovascular health.

Released: 29-Oct-2024 7:00 AM EDT
Feeling Constipated? You May Have a Higher Risk for Heart Disease
American Physiological Society (APS)

People with constipation may have a higher risk of having a heart attack or stroke, and the risk increases in people who also have high blood pressure. The findings of a new study are published in the American Journal of Physiology-Heart and Circulatory Physiology. The study has been chosen as an APSselect article for October.

Newswise: Am I Having a Stroke? What Should I do?
Released: 24-Oct-2024 2:20 PM EDT
Am I Having a Stroke? What Should I do?
Hackensack Meridian Health

Many people think a stroke is a condition that impacts the heart - when instead, it’s a condition that impacts the brain. A Hackensack Meridian Health expert shares what you need to know about types of stroke, signs and symptoms, and treatments that can help if addressed early enough.

Newswise: navbar-logo.png
18-Oct-2024 8:00 AM EDT
Study Shows Rates of Sensitization in Chicago to Outdoor Allergens Increased Post-COVID
American College of Allergy, Asthma and Immunology (ACAAI)

People have heard for years that climate change is having a significant impact on plant vegetation patterns and influencing how pollen and mold produce. A new study being presented at this year’s American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Boston showed that, in Chicago, there has been a significant increase in sensitization to pollens and molds in patients with nasal allergies.

Released: 22-Oct-2024 7:00 AM EDT
Brain Blood Flow Resistance More Common in Older Adults with Cognitive Problems
American Physiological Society (APS)

Older adults with mild cognitive impairment showed greater resistance to brain blood flow compared to those without cognitive impediments.

Newswise:Video Embedded the-university-of-rochester-live-event-on-hodgkin-lymphoma
VIDEO
14-Oct-2024 7:05 PM EDT
Video and Transcript Available: Virtual Press Briefing on Embargoed Hodgkin Lymphoma Clinical Trial
Newswise

Reporters are invited to this briefing about research from the Wilmot Cancer Institute at the University of Rochester Medical Center, with a new study to be published in the New England Journal of Medicine (NEJM).

Newswise: Researchers Awarded $1.3M to Help Military Veterans Battling Acute Myeloid Leukemia
Released: 15-Oct-2024 9:00 AM EDT
Researchers Awarded $1.3M to Help Military Veterans Battling Acute Myeloid Leukemia
Case Western Reserve University

Case Western Reserve University researchers are investigating a new approach to treat Acute Myeloid Leukemia (AML) in military Veterans.

Newswise: Experts to Discuss the Importance of Blood for Trauma Patients Before Arriving at the Hospital
Released: 14-Oct-2024 2:30 PM EDT
Experts to Discuss the Importance of Blood for Trauma Patients Before Arriving at the Hospital
American College of Surgeons (ACS)

Leading experts in trauma and critical care surgery will convene at a news conference on Monday, October 21, to discuss the lifesaving potential of making prehospital whole blood — blood administered before arriving at a hospital — widely available on ambulances across the United States.

Newswise: UTHealth Houston Awarded $2.5 Million Grant to Improve Outcomes for Stroke Patients with Large Blood Vessel Blockages
Released: 9-Oct-2024 8:05 AM EDT
UTHealth Houston Awarded $2.5 Million Grant to Improve Outcomes for Stroke Patients with Large Blood Vessel Blockages
University of Texas Health Science Center at Houston

Improving clinical outcomes in stroke patients by closing a gap between successful re-opening of a blocked vessel through endovascular surgery and a reduction of disability is the focus of a $2.5 million grant awarded to UTHealth Houston researchers.

Newswise: History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death
7-Oct-2024 9:05 AM EDT
History of COVID-19 Doubles Long-term Risk of Heart Attack, Stroke and Death
Cleveland Clinic

Cleveland: A history of COVID-19 can double the risk of heart attack, stroke or death according to new research led by Cleveland Clinic and the University of Southern California. The study found that people with any type of COVID-19 infection were twice as likely to have a major cardiac event, such as heart attack, stroke or even death, for up to three years after diagnosis.

Released: 7-Oct-2024 2:05 PM EDT
Researchers at Children’s Hospital of Philadelphia Reveal New Insights into Non-Inflammatory Causes of Rare Neurological Symptoms in Children, Adolescents and Young Adults Following CAR-T Therapy
Children's Hospital of Philadelphia

Researchers at Children’s Hospital of Philadelphia (CHOP) revealed for the first time that children, adolescents and young adults may experience very rare neurological issues of paraparesis and quadriparesis following chimeric antigen receptor T-cell (CAR-T) therapy, a type of immunotherapy used to treat B-cell Acute Lymphoblastic Leukemia (B-ALL).

Newswise: Experimental Blood Test Improves Early Detection of Pancreatic Cancer
Released: 4-Oct-2024 1:05 PM EDT
Experimental Blood Test Improves Early Detection of Pancreatic Cancer
Van Andel Institute

An experimental blood test detects early-stage pancreatic cancer more effectively than other available tests, reports a new study published in Cancer Letters.

Released: 3-Oct-2024 11:30 AM EDT
Wider Use of Convalescent Plasma Might Have Saved Thousands More Lives During Pandemic
Johns Hopkins Bloomberg School of Public Health

A new study led by researchers at Johns Hopkins Bloomberg School of Public Health estimates that thousands of lives could have been saved during the first year of the COVID-19 pandemic if convalescent plasma had been used more broadly, particularly in outpatients at high risk for severe disease and in hospitalized patients during their first few days of admission.

Newswise: Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia
Released: 30-Sep-2024 7:05 PM EDT
Study Highlights Promising New Treatment Option for Patients With Treatment-Resistant Acute Myeloid Leukemia
Roswell Park Comprehensive Cancer Center

The Clinical Leukemia Service at Roswell Park Comprehensive Cancer Center helped lead the first clinical trial of the experimental oral drug ziftomenib in patients with acute myeloid leukemia (AML).

Not for public release

This news release is embargoed until 30-Sep-2024 5:00 PM EDT Released to reporters: 24-Sep-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 30-Sep-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 26-Sep-2024 4:05 PM EDT
Ochsner Health Recognized for Innovation with HIMSS Davies Award
Ochsner Health

This prestigious validation recognizes the innovative use of technology to drive better patient care across all 46 hospitals and 390 clinics within the Ochsner system throughout the Gulf Coast region.



close
2.61785